The domestic dog, Canis lupus familiaris, is a subspecies of the gray wolf, Canis lupus, with almost identical mitochondrial DNA. The dog is the most diverse species on earth, with skull length varying between 7 and 28 cm whereas the wolf skull is around 30 cm long. However, eye size in dogs does not appear to vary as much. For example, small dogs such as the chihuahua appear to have very large eyes in proportion to the skull. Our aim was to examine eye size and retinal cell numbers and distribution to determine whether the dog eye exhibits as much variation as the skull. We found a correlation between eye radius and skull dimensions. However, the most surprising finding was that the distribution of ganglion cells in the eye varied tremendously from a horizontally aligned visual streak of fairly even density across the retina (as seen in the wolf) to a strong area centralis with virtually no streak (for example, as observed in a pug from the current series). This variation in ganglion cell density within a single species is quite unique. Intriguingly, the ratio of peak ganglion cell density in the area centralis to visual streak was highly negatively correlated with skull length (r = –0.795, n = 22) and positively correlated with cephalic index (r = 0.687, n = 22). The orientation of eyelid aperture was also correlated with cephalic index (r = 0.648, n = 22). Therefore, the genetic manipulation of selective breeding, which has produced an abnormal shortening of the skull and eyelids with less lateral apertures, has also produced a considerably more pronounced area centralis in the dog.

1.
Beazley LD, Dunlop SA (1983) The evolution of an area centralis and visual streak in the marsupial, Setonix brachyurus. J Comp Neurol 216:211–231.
2.
Coppinger R, Schneider R (1995) Evolution of working dogs. In: The Domestic Dog (Serpell J, ed), pp 21–47. Cambridge: Cambridge University Press.
3.
Dunlop SA, Beazley LD (1985) Changing distribution of ganglion cells during area centralis and visual streak formation in the marsupial, Setonix brachyurus. Dev Brain Res 23:81–90.
4.
Dunlop SA, Longley WA, Beazley LD (1987) Development of the area centralis and visual streak in the grey kangaroo, Macropus fuliginosus. Vision Res 27:151–164.
5.
Evans HE, Christensen GC (1979) Miller’s Anatomy of the Dog, 2nd ed. Philadelphia: WB Saunders.
6.
Harman AM, Beazley LD (1989) Generation of retinal cells in the wallaby, Setonix brachyurus. Neuroscience 28:219–232.
7.
Harman AM, Moore S (1999) Number of neurons in the retinal ganglion cell layer of the quokka wallaby do not change throughout life. Anat Rec 256:78–83.
8.
Harman AM, Moore S, Hoskins R, Keller P (1999) Horse vision and the explanation of visual behaviour originally explained by the ‘ramp retina’. Equine Vet J 31:384–390.
9.
Harman AM, Abrahams B, Moore SR, Hoskins R (2000) Neuronal density in the human retinal ganglion cell layer from 16–77 years. Anat Rec 260:124–131.
10.
Harman AM, Dann J, Ahmat A, Macuda T, Johnston K, Timney B (2001) The retinal ganglion cell layer and visual acuity of the camel. Brain Behav Evol 58:15–27.
11.
Hebel R (1976) Distribution of retinal ganglion cells in five mammalian species. Anat Embryol 150:45–51.
12.
Haworth K, Breen M, Binns M, Hopkinson DA, Edwards YH (2001a) The canine homeobox gene MSX2: sequence, chromosome assignment and genetic analysis in dogs of different breeds. Anim Genet 32:32–36.
13.
Haworth K, Islam I, Breen M, Putt W, Makrinou E, Binns M, Hopkinson DA, Edwards YH (2001b) Canine TCOF1; cloning, chromosome assignment and genetic analysis in dogs with different head types. Mamm Genome 12:622–629.
14.
Lehman N, Eisenhawer A, Hansen K, Mech DL, Peterson RO, Wayne RK (1991) Introgression of coyote mitochondrial DNA into sympatric North American gray wolf populations. Evolution 45:104–119.
15.
Miller PE, Murphy CJ (1995) Vision in Dogs. JAVMA 207:1623–1634.
16.
Murphy CJ, Zadnik K, Mannis MJ (1992) Myopia and refractive error in dogs. Invest Ophthalmol Vis Sci 33:2459–2463.
17.
Neitz J, Geist T, Jacobs GH (1989) Color vision in the dog. Vis Neurosci 3:119–125.
18.
Ofri R, Dawson WW, Samuelson DA (1994) Mapping of the cortical area of central vision in two dog breeds. Vet Comp Ophthalmol 4:172–178.
19.
Peichl L (1992) Topography of ganglion cells in the dog and wolf retina. J Comp Neurol 324:603–620.
20.
Provis JM, Van-Driel D, Billson FA, Russell P (1985) Development of the human retina: patterns of cell distribution and redistribution in the ganglion cell layer. J Comp Neurol 233:429–451.
21.
Robinson SR (1987) Ontogeny of the area centralis in the cat. J Comp Neurol 255:50–67.
22.
Robinson SR, Dreher B, McCall MJ (1989) Nonuniform retinal expansion during the formation of the rabbit’s visual streak: Implications for the ontogeny of mammalian retinal topography. Vis Neurosci 2:201–219.
23.
Stone J (1981) The Wholemount Handbook: A Guide to the Preparation and Analysis of Retinal Wholemounts. Sydney: Maitland Publications.
24.
Wayne RK, Jenks SM (1991) Mitochondrial DNA analysis implying extensive hybridization of the endangered red wolf (Canis rufus). Nature 351:565–568.
25.
Wayne RK, Lehman N, Allard MW, Honeycutt RL (1992). Mitochondrial DNA variability of the gray wolf: Genetic consequences of population decline and habitat fragmentation. Conserv Biol 6:559–580.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.